日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial

达格列净治疗伴或不伴2型糖尿病的COVID-19住院患者的疗效和安全性:DARE-19随机试验的预设分析

Abdel Jawad, Mohammad; Furtado, Remo H M; Esterline, Russell; Oscarsson, Jan; Gasparyan, Samvel B; Koch, Gary G; Martinez, Felipe; Mukhtar, Omar; Verma, Subodh; Langkilde, Anna Maria; Ambery, Philip; Patel, Shachi; Gosch, Kensey; Windsor, Sheryl L; Soares, Ronaldo V P; Moia, Diogo D F; Aboudara, Matthew; Javaheri, Ali; Saraiva, J F Kerr; Maia, Lilia Nigro; Berwanger, Otavio; Sauer, Andrew J; Kosiborod, Mikhail N

Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4

型糖尿病脑灌注和底物代谢的改变:与 APOE-ε4 的相互作用

Schain, Martin; Johansson, Edvin; Laitinen, Iina; Frödén Löwenmark, Anna; Lubberink, Mark; Gummesson, Anders; Danfors, Torsten; Nuutila, Pirjo; Esterline, Russell; Johansson, Lars; Oscarsson, Jan; Heurling, Kerstin

Sodium-Glucose Cotransporter Inhibition Preserves Apolipoprotein M During Acute Inflammation in Mice and Humans

钠-葡萄糖协同转运蛋白抑制剂可在小鼠和人类急性炎症期间保护载脂蛋白M

Valenzuela Ripoll, Carla; Lotfinaghsh, Aynaz; Guo, Zhen; Kumari, Tripti; Miyata, Kana N; Sargazi, Alireza; Ozcan, Mualla; Diab, Ahmed; Ataran, Anahita; Hajirezaei, Hamidreza; Rashidi, Omid; Yu, Wenjing; Cho, Yoonje; Kovacs, Attila; Weinheimer, Carla; Nigro, Jess; Cases, Olivier; Kozyraki, Renata; Oscarsson, Jan; Esterline, Russell; Levi, Moshe; Berger, Justin H; Schilling, Joel D; Apte, Rajendra S; Sardiello, Marco; Peikert, Alexander; Kosiborod, Mikhail; Adamo, Luigi; Lowenstein, Charlie; Christoffersen, Christina; Cho, Jaehyung; Javaheri, Ali

13C tracing in synaptosomes reveals that SGLT2 inhibition with dapagliflozin prevents metabolic deficits in the 5X-FAD model of Alzheimer's Disease.

13C 在突触体中的示踪显示,达格列净抑制 SGLT2 可预防 5X-FAD 阿尔茨海默病模型中的代谢缺陷

Mekkittikul Marisa, Zhu Cansheng, Danna Bezawit T, Zuo Xiaohong, Rios Amy, Yang Krista, Villanueva Miranda, Agarwal Devanshi, Castro Daniel, Gu Xuelin, Strofs Alexander R, Shirihai Orian S, Stiles Linsey, Frautschy Sally A, Oscarsson Jan, Esterline Russell L, Cole Gregory M, Divakaruni Ajit S

SGLT2 inhibition improves coronary flow velocity reserve and contractility: role of glucagon signaling

SGLT2抑制剂可改善冠状动脉血流速度储备和收缩力:胰高血糖素信号传导的作用

Göpel, Sven O; Adingupu, Damilola; Wang, Jue; Semenova, Elizaveta; Behrendt, Margareta; Jansson-Löfmark, Rasmus; Ahlström, Christine; Jönsson-Rylander, Ann-Cathrine; Gopaul, V Sashi; Esterline, Russell; Gan, Li-Ming; Xiao, Rui-Ping

Dapagliflozin in patients with COVID-19: mind the kidneys - Authors' reply

达格列净用于新冠肺炎患者:注意肾脏——作者回复

Kosiborod, Mikhail N; Esterline, Russell; Oscarsson, Jan; Gasparyan, Samvel B; Furtado, Remo H M; Verma, Subodh; Berwanger, Otavio

Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection: An Analysis of the DARE-19 Randomized Controlled Trial

达格列净对新冠肺炎住院患者肾脏结局的影响:DARE-19随机对照试验分析

Heerspink, Hiddo J L; Furtado, Remo H M; Berwanger, Otavio; Koch, Gary G; Martinez, Felipe; Mukhtar, Omar; Verma, Subodh; Gasparyan, Samvel B; Tang, Fengming; Windsor, Sheryl L; de Souza-Dantas, Vicente Cés; Del Sueldo, Mildren; Frankel, Robert; Javaheri, Ali; Maldonado, Rafael A; Morse, Caryn; Mota-Gomes, Marco; Shemin, Douglas; Silva, Osvaldo Lourenço Jr; Tognon, Alexandre Pereira; Twahirwa, Marcel; Buenconsejo, Joan; Esterline, Russell; Oscarsson, Jan; Ambery, Philip; Langkilde, Anna Maria; Kosiborod, Mikhail N

Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism

SGLT2抑制剂达格列净对2型糖尿病患者骨骼肌细胞代谢的影响

Yvo J M Op den Kamp, Anne Gemmink, Marlies de Ligt, Bas Dautzenberg, Esther Kornips, Johanna A Jorgensen, Gert Schaart, Russell Esterline, Diego A Pava, Joris Hoeks, Vera B Schrauwen-Hinderling, Sander Kersten, Bas Havekes, Timothy R Koves, Deborah M Muoio, Matthijs K C Hesselink, Jan Oscarsson, Est

Differential In Vitro Effects of SGLT2 Inhibitors on Mitochondrial Oxidative Phosphorylation, Glucose Uptake and Cell Metabolism

SGLT2 抑制剂对线粒体氧化磷酸化、葡萄糖摄取和细胞代谢的不同体外影响

Elmar Zügner, Hsiu-Chiung Yang, Petra Kotzbeck, Beate Boulgaropoulos, Harald Sourij, Sepideh Hagvall, Charles S Elmore, Russell Esterline, Sven Moosmang, Jan Oscarsson, Thomas R Pieber, Xiao-Rong Peng, Christoph Magnes

Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial

达格列净治疗伴有心血管代谢风险因素的COVID-19住院患者(DARE-19):一项随机、双盲、安慰剂对照的3期试验

Kosiborod, Mikhail N; Esterline, Russell; Furtado, Remo H M; Oscarsson, Jan; Gasparyan, Samvel B; Koch, Gary G; Martinez, Felipe; Mukhtar, Omar; Verma, Subodh; Chopra, Vijay; Buenconsejo, Joan; Langkilde, Anna Maria; Ambery, Philip; Tang, Fengming; Gosch, Kensey; Windsor, Sheryl L; Akin, Emily E; Soares, Ronaldo V P; Moia, Diogo D F; Aboudara, Matthew; Hoffmann Filho, Conrado Roberto; Feitosa, Audes D M; Fonseca, Alberto; Garla, Vishnu; Gordon, Robert A; Javaheri, Ali; Jaeger, Cristiano P; Leaes, Paulo E; Nassif, Michael; Pursley, Michael; Silveira, Fabio Serra; Barroso, Weimar Kunz Sebba; Lazcano Soto, José Roberto; Nigro Maia, Lilia; Berwanger, Otavio